Nextage Therapeutics (Israel) Probability of Future Stock Price Finishing Over 72.50
| NXTG Stock | ILA 72.50 4.90 7.25% |
Nextage |
Nextage Therapeutics Target Price Odds to finish over 72.50
The tendency of Nextage Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 72.50 | 90 days | 72.50 | near 1 |
Based on a normal probability distribution, the odds of Nextage Therapeutics to move above the current price in 90 days from now is near 1 (This Nextage Therapeutics probability density function shows the probability of Nextage Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Nextage Therapeutics has a beta of -4.55. This indicates as returns on its benchmark rise, returns on holding Nextage Therapeutics are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Nextage Therapeutics is expected to outperform its benchmark. In addition to that Nextage Therapeutics has an alpha of 2.118, implying that it can generate a 2.12 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Nextage Therapeutics Price Density |
| Price |
Predictive Modules for Nextage Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nextage Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nextage Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nextage Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Nextage Therapeutics is not an exception. The market had few large corrections towards the Nextage Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Nextage Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Nextage Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 2.12 | |
β | Beta against NYSE Composite | -4.55 | |
σ | Overall volatility | 10.39 | |
Ir | Information ratio | 0.14 |
Nextage Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Nextage Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Nextage Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Nextage Therapeutics is way too risky over 90 days horizon | |
| Nextage Therapeutics appears to be risky and price may revert if volatility continues | |
| The company has accumulated 1.11 M in total debt. Nextage Therapeutics has a current ratio of 0.43, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nextage Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Nextage Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nextage Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nextage to invest in growth at high rates of return. When we think about Nextage Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 91 K. Net Loss for the year was (7.73 M) with profit before overhead, payroll, taxes, and interest of 16 K. | |
| Nextage Therapeutics has accumulated about 358 K in cash with (3.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| Roughly 82.0% of the company outstanding shares are owned by corporate insiders |
Nextage Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Nextage Stock often depends not only on the future outlook of the current and potential Nextage Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nextage Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.1 M | |
| Short Long Term Debt | 202 K |
Nextage Therapeutics Technical Analysis
Nextage Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Nextage Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Nextage Therapeutics. In general, you should focus on analyzing Nextage Stock price patterns and their correlations with different microeconomic environments and drivers.
Nextage Therapeutics Predictive Forecast Models
Nextage Therapeutics' time-series forecasting models is one of many Nextage Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Nextage Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Nextage Therapeutics
Checking the ongoing alerts about Nextage Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Nextage Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Nextage Therapeutics is way too risky over 90 days horizon | |
| Nextage Therapeutics appears to be risky and price may revert if volatility continues | |
| The company has accumulated 1.11 M in total debt. Nextage Therapeutics has a current ratio of 0.43, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Nextage Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Nextage Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nextage Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nextage to invest in growth at high rates of return. When we think about Nextage Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 91 K. Net Loss for the year was (7.73 M) with profit before overhead, payroll, taxes, and interest of 16 K. | |
| Nextage Therapeutics has accumulated about 358 K in cash with (3.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16. | |
| Roughly 82.0% of the company outstanding shares are owned by corporate insiders |
Check out Nextage Therapeutics Backtesting, Nextage Therapeutics Valuation, Nextage Therapeutics Correlation, Nextage Therapeutics Hype Analysis, Nextage Therapeutics Volatility, Nextage Therapeutics History as well as Nextage Therapeutics Performance. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |